Quetiapine

Chemical formula: C₂₁H₂₅N₃O₂S  Molecular mass: 383.507 g/mol  PubChem compound: 5002

Therapeutic indications

Quetiapine is indicated for:

Schizophrenia, moderate to severe manic episodes in bipolar disorder

Population group: only adults (18 years old or older)

at least one of
Schizophrenia
Moderate manic bipolar I disorder
Severe bipolar I disorder, single manic episode with psychotic features
Severe bipolar I disorder, single manic episode without psychotic features

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Major depressive episodes in bipolar disorder

Population group: only adults (18 years old or older)

Bipolar II disorder, most recent episode major depressive

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Preventing recurrence in bipolar disorder

Population group: only adults (18 years old or older)

Bipolar disorder

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD)

Population group: only adults (18 years old or older)

Add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had suboptimal response to antidepressant monotherapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD)

Population group: only elderly (65 years old or older)

Add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had suboptimal response to antidepressant monotherapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Quetiapine is contraindicated in the following cases:

CYP3A4 inhibitors

CYP3A4 inhibitors

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2021: ATROLAK Prolonged-release tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈